Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Cipla
Merck
UBS
QuintilesIMS
Baxter
Express Scripts
US Department of Justice

Generated: June 20, 2018

DrugPatentWatch Database Preview

BETAGAN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Betagan patents expire, and when can generic versions of Betagan launch?

Betagan is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BETAGAN is levobunolol hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for BETAGAN
US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: 2
Bulk Api Vendors: 59
Patent Applications: 465
DailyMed Link:BETAGAN at DailyMed
Drug patent expirations by year for BETAGAN
Pharmacology for BETAGAN
Medical Subject Heading (MeSH) Categories for BETAGAN

US Patents and Regulatory Information for BETAGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan BETAGAN levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019814-001 Jun 28, 1989 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan BETAGAN levobunolol hydrochloride SOLUTION/DROPS;OPHTHALMIC 019219-002 Dec 19, 1985 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Mallinckrodt
Harvard Business School
Healthtrust
Chubb
QuintilesIMS
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.